Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.

Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study. J Immunother Cancer. 2024 Nov 03; 12(11).

View in: PubMed

subject areas

Adult
Aged
Biomarkers, Tumor
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Programmed Cell Death 1 Receptor

authors with profiles

Ezra Cohen